- Home
- SYRA vs ADXN Comparison
SYRA vs ADXN Comparison
Compare SYRA & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRA
- ADXN
- Stock Information
- Founded
- SYRA 2020
- ADXN 2002
- Country
- SYRA United States
- ADXN Switzerland
- Employees
- SYRA N/A
- ADXN N/A
- Industry
- SYRA Other Specialty Stores
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- SYRA Industrials
- ADXN Health Care
- Exchange
- SYRA Nasdaq
- ADXN Nasdaq
- Market Cap
- SYRA 7.8M
- ADXN 11.3M
- IPO Year
- SYRA 2023
- ADXN N/A
- Fundamental
- Price
- SYRA $0.42
- ADXN $11.26
- Analyst Decision
- SYRA
- ADXN Strong Buy
- Analyst Count
- SYRA 0
- ADXN 1
- Target Price
- SYRA N/A
- ADXN $30.00
- AVG Volume (30 Days)
- SYRA 122.9K
- ADXN 24.7K
- Earning Date
- SYRA 10-29-2024
- ADXN 11-11-2024
- Dividend Yield
- SYRA N/A
- ADXN N/A
- EPS Growth
- SYRA N/A
- ADXN N/A
- EPS
- SYRA N/A
- ADXN 0.05
- Revenue
- SYRA $7,069,566.00
- ADXN $960,641.00
- Revenue This Year
- SYRA $42.88
- ADXN N/A
- Revenue Next Year
- SYRA N/A
- ADXN N/A
- P/E Ratio
- SYRA N/A
- ADXN $1.87
- Revenue Growth
- SYRA 25.18
- ADXN N/A
- 52 Week Low
- SYRA $0.34
- ADXN $5.00
- 52 Week High
- SYRA $8.37
- ADXN $27.90
- Technical
- Relative Strength Index (RSI)
- SYRA 42.80
- ADXN 64.36
- Support Level
- SYRA $0.35
- ADXN $10.04
- Resistance Level
- SYRA $0.46
- ADXN $10.81
- Average True Range (ATR)
- SYRA 0.03
- ADXN 0.63
- MACD
- SYRA 0.03
- ADXN 0.08
- Stochastic Oscillator
- SYRA 80.28
- ADXN 86.17
About SYRA Syra Health Corp.
Syra Health Corp is a healthcare services company promoting preventative health, holistic wellness, health education, and equitable healthcare for all patient demographics. The company leverages deep scientific and healthcare expertise to create strategic frameworks and develop patient-centric solutions for the betterment of patient lives and health outcome linked to developing a healthier population. It strives to offer comprehensive end-to-end solutions in health education services, population health management, behavioral and mental health, healthcare workforce and digital health.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.